147 related articles for article (PubMed ID: 21793275)
1. Efficacy of vaginal use of topical estriol in postmenopausal women with urogenital atrophy.
Chuery AC; Speck NM; de Moura KF; Belfort PN; Sakano C; Ribalta JC
Clin Exp Obstet Gynecol; 2011; 38(2):143-5. PubMed ID: 21793275
[TBL] [Abstract][Full Text] [Related]
2. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
[TBL] [Abstract][Full Text] [Related]
3. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women.
Capobianco G; Donolo E; Borghero G; Dessole F; Cherchi PL; Dessole S
Arch Gynecol Obstet; 2012 Feb; 285(2):397-403. PubMed ID: 21706345
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
[TBL] [Abstract][Full Text] [Related]
5. Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women.
Capobianco G; Wenger JM; Meloni GB; Dessole M; Cherchi PL; Dessole S
Arch Gynecol Obstet; 2014 Mar; 289(3):601-8. PubMed ID: 24057079
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral estriol on urogenital symptoms, vaginal cytology, and plasma hormone level in postmenopausal women.
Manonai J; Theppisai U
J Med Assoc Thai; 2001 Apr; 84(4):539-44. PubMed ID: 11460966
[TBL] [Abstract][Full Text] [Related]
7. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.
Henriksson L; Stjernquist M; Boquist L; Alander U; Selinus I
Am J Obstet Gynecol; 1994 Sep; 171(3):624-32. PubMed ID: 8092207
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review.
Rueda C; Osorio AM; Avellaneda AC; Pinzón CE; Restrepo OI
Climacteric; 2017 Aug; 20(4):321-330. PubMed ID: 28622049
[TBL] [Abstract][Full Text] [Related]
10. Effect and safety of 17 beta-estradiol vaginal tablet in postmenopausal women with urogenital symptoms.
Manonai J; Theppisai U; Chittacharoen A
J Med Assoc Thai; 2001 Jul; 84(7):1015-20. PubMed ID: 11759960
[TBL] [Abstract][Full Text] [Related]
11. Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?
Matarazzo MG; Caruso S; Giunta G; Valenti G; Sarpietro G; Cianci A
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():75-79. PubMed ID: 29367168
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of climacteric urogenital disorders with an estriol-containing ointment].
Koloszár S; Kovács L
Orv Hetil; 1995 Feb; 136(7):343-5. PubMed ID: 7870416
[TBL] [Abstract][Full Text] [Related]
13. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.
Barentsen R; van de Weijer PH; Schram JH
Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):73-80. PubMed ID: 9031963
[TBL] [Abstract][Full Text] [Related]
14. Treatment of urogenital atrophy with low-dose estradiol: preliminary results.
Santen RJ; Pinkerton JV; Conaway M; Ropka M; Wisniewski L; Demers L; Klein KO
Menopause; 2002; 9(3):179-87. PubMed ID: 11973441
[TBL] [Abstract][Full Text] [Related]
15. [The role of estriol in therapy of urogenital disorders in postmenopausal women].
Perepanova TS; Khazan PL
Urologiia; 2007; (3):102-4, 107. PubMed ID: 17722629
[No Abstract] [Full Text] [Related]
16. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women.
Cruz VL; Steiner ML; Pompei LM; Strufaldi R; Fonseca FLA; Santiago LHS; Wajsfeld T; Fernandes CE
Menopause; 2018 Jan; 25(1):21-28. PubMed ID: 28763401
[TBL] [Abstract][Full Text] [Related]
17. [Effect of vaginal estriol on urogenital symptoms in postmenopausal women].
Hejlová P; Zivný J
Ceska Gynekol; 2004 Jul; 69(4):329-35. PubMed ID: 15369256
[TBL] [Abstract][Full Text] [Related]
18. Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.
Donders G; Neven P; Moegele M; Lintermans A; Bellen G; Prasauskas V; Grob P; Ortmann O; Buchholz S
Breast Cancer Res Treat; 2014 Jun; 145(2):371-9. PubMed ID: 24718774
[TBL] [Abstract][Full Text] [Related]
19. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.
Biglia N; Peano E; Sgandurra P; Moggio G; Panuccio E; Migliardi M; Ravarino N; Ponzone R; Sismondi P
Gynecol Endocrinol; 2010 Jun; 26(6):404-12. PubMed ID: 20196634
[TBL] [Abstract][Full Text] [Related]
20. [Postmenopausal vaginal atrophy and topical therapy with an estriol-based ointment (Colpogyn): authors' experience].
Oliva FA; Saltarelli E; D'Antonio GD; Mazzatenta E
Minerva Ginecol; 1991 Dec; 43(12):605-7. PubMed ID: 1819780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
